Menu

Applied Therapeutics, Inc. APLT

Full chart Compare
Set alert

Price alert · APLT

All alert types
0.10 USD 0.00 (+0.00%)

At closeJul 2, 2026, 4:00 PM EDT

0.11 0.00 +2.04%

After hours · Jul 2, 4:00 PM ET

0.103 Day range 0.103
0.78 52-week range 10.62
YTD
+3.00%
1 year
-81.62%

Revenue & Expenses

Other Operating Income → Expenses: $48.74MExpenses → Gross Loss: $48.29MExpenses → Selling, General & Admin: $56.01MExpenses → Research & Development: $48.74MExpenses → Other Expenses: $1.32MNet Loss → Expenses: $105.62MRevenue → Cost of Revenue: $455.00KOther Operating Income$48.74MNet Loss$105.62MCost of Revenue$48.74MExpenses$154.37MGross Loss$48.29MSelling, General & Admin$56.01MResearch & Development$48.74MOther Expenses$1.32MRevenue$455.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

APLT annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
455.00K9.99M000
455.00K9.99M000
-104.30M-64.53M-82.95M-105.62M-94.47M
-105.62M-119.76M-82.51M-105.58M-93.96M
-0.76-1.42-2.18-4.12-4.28
APLT annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
79.40M49.90M16.66M53.89M57.47M
86.69M54.83M38.36M89.89M104.51M
29.68M71.98M34.30M27.35M22.57M
2.79M467.00K891.00K1.33M1.74M
57.01M-17.15M4.06M62.54M81.94M
APLT annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-84.31M-55.17M-78.09M-90.73M-78.21M
113.81M74.54M27.69M74.72M136.29M
29.50M33.24M-37.23M-3.58M38.62M